Similar articles

• Aspergillosis.

  Segal BH. Segal BH. N Engl J Med. 2009 Apr 30;360(18):1870-84. doi: 10.1056/NEJMra0808853. N Engl J Med. 2009. PMID: 19403905 Review. No abstract available.
• Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.

  Takemoto K, Yamamoto Y, Ueda Y, Kanazawa K, Yoshida K, Niki Y. Takemoto K, et al. Chemotherapy. 2009;55(2):105-13. doi: 10.1159/000194661. Epub 2009 Jan 19. Chemotherapy. 2009. PMID: 19151551
• [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].

  Piñar D, Reus S, Pérez P, Quiles JA. Piñar D, et al. Enferm Infecc Microbiol Clin. 2010 Jan;28(1):66-7. doi: 10.1016/j.eimc.2009.02.009. Epub 2009 May 5. Enferm Infecc Microbiol Clin. 2010. PMID: 19419799 Spanish. No abstract available.
• Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.

  Hilberg O, Andersen CU, Henning O, Lundby T, Mortensen J, Bendstrup E. Hilberg O, et al. Eur Respir J. 2012 Jul;40(1):271-3. doi: 10.1183/09031936.00163511. Eur Respir J. 2012. PMID: 22753838 No abstract available.
• [The future of antifungal agents].

  Maesaki S. Maesaki S. Rinsho Ketsueki. 2007 Jan;48(1):26-35. Rinsho Ketsueki. 2007. PMID: 17313074 Review. Japanese. No abstract available.